CellCarta News and Activities

View the org chart displaying its 21 main executives

Most searched biographies at CellCarta

• Dusty Tenney, Chief Executive Officer
• Dirk Hendriks, Director
• Josh Schultz, Chairman of the Board

Popular executive movements at CellCarta

• Ehab Elgabry has joined the company as Chief Medical Officer and Head of Companion Diagnostics  (posted on March 3 2026).
• Mark Kockx, Chief Medical and Scientific Officer, has left the company  (posted on March 3 2026).
• Jon Denissen has joined the company as Director  (posted on December 4 2025).

Create your alert
to follow the executive moves at CellCarta.

CellCarta has 2,414 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).
• Osanni Bio has just announced a $190 Million fundraising (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by CellCarta

Social media about CellCarta

• CellCarta on Wikipedia, Google News & Yahoo Finance
• CellCarta on LinkedIn, X (Twitter) & YouTube